J. Reynolds

发表

SYK inhibition attenuates autoantibody production and reverses Experimental Autoimmune Glomerulonephritis

E. Masuda, F. Tam, J. McDaid, 2015 .

Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.

E. Masuda, C. Pusey, F. Tam, 2014, Journal of the American Society of Nephrology : JASN.

Segregation of Experimental Autoimmune Glomerulonephritis as a Complex Genetic Trait and Exclusion of Col4a3 as a Candidate Gene

A. Glazier, T. Aitman, C. Pusey, 2002, Nephron Experimental Nephrology.

Dialysis Transplantation Experimental autoimmune glomerulonephritis ( EAG ) induced by homologous and heterologous glomerular basement membrane in two substrains of Wistar-Kyoto rat

S. J. Cashman, C. Pusey, D. Evans, 2011 .

CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis.

R. Peach, M. Sayegh, C. Pusey, 2000, The Journal of clinical investigation.

Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.

C. Benjamin, C. Pusey, A. Allen, 2004, Kidney international.

Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat.

C. Pusey, M. Duda, David J. Evans, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis.

C. Pusey, H. Cook, U. Bhambra, 2002, Journal of the American Society of Nephrology : JASN.

Increased incidence of anti-GBM disease in Fcgamma receptor 2b deficient mice, but not mice with conditional deletion of Fcgr2b on either B cells or myeloid cells alone.

J. Moss, C. Pusey, J. Verbeek, 2012, Molecular immunology.

Immunopathology and Infectious Diseases Mucosal Tolerance Induced by an Immunodominant Peptide from Rat 3 ( IV ) NC 1 in Established Experimental Autoimmune Glomerulonephritis

C. Pusey, David J. Evans, J. Reynolds, 2010 .

Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis

C. Pusey, J. Haxby, D. Evans, 2009, Clinical and experimental immunology.

Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat

S. J. Cashman, C. Pusey, J. Reynolds, 1991, Clinical and experimental immunology.

Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritis.

A. Salama, C. Pusey, H. Cook, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Journal ClubAuthors' reply:

C. Pusey, J. Reynolds, 2001 .

Glomerular T Cells Are of Restricted Clonality and Express Multiple CDR3 Motifs across Different Vβ T-Cell Receptor Families in Experimental Autoimmune Glomerulonephritis

A. Habib, C. Pusey, Hui-ling Wu, 2004, Nephron Experimental Nephrology.

The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease

D. Woodrow, J. Moss, C. Pusey, 2003, The Journal of pathology.

Cardiovascular , Pulmonary , and Renal Pathology Genetic Susceptibility to Experimental Autoimmune Glomerulonephritis in the Wistar Kyoto Rat

T. Aitman, A. Salama, C. Pusey, 2012 .

Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.

C. Pusey, J. Reynolds, 2001, Journal of the American Society of Nephrology : JASN.

In vivo treatment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis in the BN rat

C. Pusey, J. Reynolds, 1994, Clinical and experimental immunology.

The role of T-helper lymphocytes in priming for experimental autoimmune glomerulonephritis in the BN rat.

C. Pusey, B. Sallie, C. Syrganis, 1993, Journal of autoimmunity.

Lung - Obliterative Bronchiolitis Post Role of Complement Activation in

E. Mickler, G. Sandusky, M. Lasbury, 2013 .

Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'.

C. Pusey, D. Bunch, H. Cook, 2015, Journal of autoimmunity.

Strain differences and the genetic basis of experimental autoimmune anti‐glomerular basement membrane glomerulonephritis

J. Reynolds, 2011, International journal of experimental pathology.

Expression and characterization of recombinant rat alpha 3(IV)NC1 and its use in induction of experimental autoimmune glomerulonephritis.

C. Pusey, J. Ryan, J. Reynolds, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.

R. Kalluri, C. Pusey, E. Prodromidi, 2005, Journal of the American Society of Nephrology : JASN.

Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat.

T. Aitman, G. Bhangal, J. Behmoaras, 2012, The American journal of pathology.

Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis.

J. Reynolds, J. Karegli, Danielle S Abbott, 2009, The American journal of pathology.

Increased incidence of anti-GBM disease in Fcgamma receptor 2b deficient mice, but not mice with conditional deletion of Fcgr2b on either B cells or myeloid cells alone.

J. Moss, P. Boross, S. Mangsbo, 2012, Molecular immunology.